Genetesis Inc.
A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.
Coronary; Ischemic
CardioFlux Magnetocardiography
Study Type : | OBSERVATIONAL |
Estimated Enrollment : | 300 participants |
Official Title : | A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients with Suspected Coronary Ischemia. |
Actual Study Start Date : | 2023-08-28 |
Estimated Primary Completion Date : | 2025-06-01 |
Estimated Study Completion Date : | 2025-12-31 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 40 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Cleveland Clinic
Cleveland, Ohio, United States, 44195
RECRUITING
Kettering Health
Kettering, Ohio, United States, 45429